Geode Capital Management’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.1M Buy
4,725,154
+346,685
+8% +$2.41M ﹤0.01% 1780
2025
Q4
$30.8M Buy
4,378,469
+416,404
+11% +$2.51M ﹤0.01% 1772
2025
Q3
$21.8M Buy
3,962,065
+596,662
+18% +$2.92M ﹤0.01% 1954
2025
Q2
$17.4M Sell
3,365,403
-141,510
-4% -$848K ﹤0.01% 2024
2025
Q1
$23.4M Buy
3,506,913
+41,442
+1% +$315K ﹤0.01% 1821
2024
Q4
$25.5M Buy
3,465,471
+13,293
+0.4% +$95.4K ﹤0.01% 1829
2024
Q3
$24.2M Buy
3,452,178
+729,794
+27% +$4.39M ﹤0.01% 1880
2024
Q2
$13.4M Buy
2,722,384
+246,134
+10% +$1.48M ﹤0.01% 2151
2024
Q1
$15.3M Buy
2,476,250
+60,261
+2% +$406K ﹤0.01% 2081
2023
Q4
$18.9M Buy
2,415,989
+98,119
+4% +$632K ﹤0.01% 1955
2023
Q3
$15.9M Buy
2,317,870
+56,476
+2% +$458K ﹤0.01% 1964
2023
Q2
$20.6M Buy
2,261,394
+429,132
+23% +$3.57M ﹤0.01% 1835
2023
Q1
$13.6M Buy
1,832,262
+56,631
+3% +$314K ﹤0.01% 2058
2022
Q4
$8.77M Buy
1,775,631
+29,283
+2% +$181K ﹤0.01% 2349
2022
Q3
$11.6M Buy
1,746,348
+502,175
+40% +$3.5M ﹤0.01% 2131
2022
Q2
$6.92M Sell
1,244,173
-5,189
-0.4% -$39.7K ﹤0.01% 2507
2022
Q1
$12.6M Buy
1,249,362
+265,811
+27% +$2.33M ﹤0.01% 2190
2021
Q4
$9.36M Buy
983,551
+7,899
+0.8% +$83.8K ﹤0.01% 2484
2021
Q3
$14.1M Buy
975,652
+699,377
+253% +$13.5M ﹤0.01% 2203
2021
Q2
$7.7M Buy
+276,275
New +$7.3M ﹤0.01% 2642

Other funds holding LFST

Geode Capital Management's LFST Position: Q1 2026 in Review

Geode Capital Management increased its Lifestance Health (LFST) stake by 7.9% in Q1 2026, buying an estimated $2.41M and bringing the position to 4,725,154 shares worth $30.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1780.

Geode Capital Management first reported a position in LFST in Q2 2021 and has held it in 20 quarters since. The position peaked at $30.8M in Q4 2025. 229 funds tracked by Wall St. Rank hold LFST as of Q1 2026.

  • Geode Capital Management held 4,725,154 shares of Lifestance Health worth $30.1M as of Q1 2026.
  • Geode Capital Management bought 346,685 Lifestance Health shares in Q1 2026, an estimated $2.41M.
  • Lifestance Health made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #1780 holding.
  • Geode Capital Management first reported a position in Lifestance Health in Q2 2021 and has held it in 20 quarters since.
  • Geode Capital Management's Lifestance Health position peaked at $30.8M in Q4 2025.
  • 229 funds tracked by Wall St. Rank held Lifestance Health as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.